All Posts: lung cancer
-
Routine Lung Screening Spots Aggressive Cancer Early, Allows Successful Treatment
The detection of an aggressive form of lung cancer in a patient treated by experts at Georgetown University’s Lombardi Comprehensive Cancer Center demonstrates the importance of routine screenings and a strong relationship between patients and their primary care physicians.
Category: GUMC Stories
-
FDA Approves Lung Cancer Drug Supported by Georgetown Lombardi Research
Category: GUMC Stories
-
Adding Smoking Cessation to Lung Cancer Screening Can Reduce Mortality by 14%
Category: News Release
-
When Enough is Enough! Smoking Cessation at Georgetown Lombardi
Category: GUMC Stories
-
Rare but Important Gene Target Found in Many Tumor Types, Suggesting New Therapy Possible
Category: News Release
-
Georgetown-Led Study Leads to First FDA-Approved Drug in Decades to Improve Survival in Small Cell Lung Cancer
MEDIA CONTACT:Karen Teberkm463@georgetown.edu WASHINGTON (March 18, 2019) — The U.S. Food and Drug Administration’s approval today of atezolizumab (Tecentriq®, Genentech) in combination with chemotherapy (carboplatin and etoposide) for the initial treatment of extensive-stage small cell lung cancer (SCLC) marks the end of numerous failed attempts to improve survival for those with the deadly disease. “Atezolizumab, […]
Category: News Release